Hydralazine Hydrochloride Tablet, Film Coated
Product Images NDC 63187-901

2 FDA label images from Proficient Rx Lp · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Hydralazine Hydrochloride (NDC 63187-901). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

A9cb621b-figure-01 (A9cb621b Figure 01)

A9cb621b-figure-01 (A9cb621b Figure 01)
Chemical structure diagram of Hydralazine Hydrochloride, depicting the molecular arrangement including rings and attached groups labeled NHNH2 and HCl.*
FDA Label Image

63187-901-30 (A9cb621b Figure 03)

63187-901-30 (A9cb621b Figure 03)
Label for Hydralazine Hydrochloride 25 mg film-coated tablets by Proficient Rx LP. The package contains 90 tablets. The label details the active ingredient as Hydralazine Hydrochloride, USP, in each tablet. Describes the tablets as round, convex, pink, with specific engraving. Manufacturer is Heritage Pharmaceuticals Inc., East Brunswick, NJ.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.